A common reason patients and their families consult me is: “I just had a coronary angiogram done and it showed 3 (or 4 or 5) blockages. The doctor recommended immediate bypass surgery. Is bypass surgery really needed? And will it help me live longer?”
In other words, bypass surgery can help certain patients with several blockages in the heart arteries live longer, better lives.
For adults managing heart disease in India, making the choice between medical therapy, stents, or major surgery can be daunting, but understanding the latest 10-year survival data can help you make a confident, life-saving decision.
The Long-Term Advantage of Surgery
When it comes to treating blocked heart arteries, the two most common procedures are Percutaneous Coronary Intervention (PCI, commonly known as angioplasty and stenting) and Coronary Artery Bypass Grafting (CABG, or bypass surgery).
Angioplasty and stenting is often best for patients with one or two blockages, and offers the advantages of being less invasive with a quicker recovery. This is an ideal choice for an acute heart attack (myocardial infarction), and also for patients with one or two blockages where symptoms are not controlled by medicines alone.
But for more complex cases where several blockages are present, long-term studies increasingly favor surgery for helping patients live longer.
A comprehensive 2022 meta-analysis reviewing 7,181 patients across six randomized trials demonstrated that getting stents (PCI) was associated with a higher 10-year all-cause mortality risk (chance of dying) compared to undergoing a bypass. This survival benefit of surgery was particularly strong for patients who had moderate-to-high “SYNTAX scores,” which is a medical grading system used to measure the complexity of coronary artery disease. In other words, the worse or more complicated the blockages, the better bypass surgery did in helping patients live longer.
Who Benefits the Most?
Medical science is not one-size-fits-all. The data highlights specific groups of patients who clearly live longer when they choose bypass surgery over stents:
Patients with Multi-Vessel Disease
If you have blockages in three major heart vessels (3VD), surgery provides a clear advantage. A 2025 retrospective study found that the 10-year mortality rate was significantly lower for bypass patients (62.4%) compared to those who received stents (71.8%). Furthermore, those who had surgery had far fewer hospital readmissions for heart attacks.
Patients with Diabetes
Diabetes aggressively impacts blood vessels, making heart disease harder to treat. A 2018 study confirmed that diabetic patients with multi-vessel disease who underwent a bypass had a significantly lower mortality rate (49.6%) compared to those treated with stents (57.6%) over a median follow-up of 8 to 9 years.
Patients with Weakened Heart Muscles
For patients with ischemic cardiomyopathy — a condition where restricted blood flow weakens the heart’s pumping ability — surgery offers a new lease on life. A landmark study of 2,136 patients showed that bypass surgery, when added to optimal medical therapy, significantly reduces all-cause mortality and cardiovascular death compared to medical therapy alone.
Older Adults and Complex Cases
Bypass surgery has become much safer in recent years thanks to advances in surgical techniques and post-surgical care. A 2024 Spanish Registry Study highlighted that bypass mortality dropped from 5.6% to 4.8% between 2010 and 2019. This improvement specifically benefited highly complex cases, including patients over the age of 80 and those with diabetes, while the mortality rates for stent procedures remained stable or slightly increased during the same period.
Summary
While medications and angioplasty/stents are excellent tools for managing simple blockages and relieving chest pain, they are not always the best choice for long-term survival in complex disease. Bypass surgery remains the standard of care if you have blockages in multiple arteries, have a blockage in the left main coronary artery, suffer from diabetes, or have a weakened heart. Always consult with your cardiologist to carefully review your angiogram and determine which intervention offers you the best length and quality of life.
Reviewed for medical accuracy by Dr. Srikanth Sola. Last updated: March 24, 2026
References for detailed reading
- Gaudino, M., et al. (2022). “Ten-Year Outcomes After Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis.” Journal of the American College of Cardiology.
- Farkouh, M. E., et al. (2018). “Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes (FREEDOM Trial Follow-up).” Journal of the American College of Cardiology.
- Velazquez, E. J., et al. (2016). “Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.” The New England Journal of Medicine.
- Díaz, J. F., et al. (2024). “Trends in Coronary Revascularization Outcomes: Insights from the Spanish National Registry.” European Heart Journal.